BiomX PHGE +46.67% ▲ stock rocketed higher on Wednesday after the clinical-stage microbiome company filed a shareholder update with the Securities and Exchange Commission (SEC). In this filing, the company revealed that Morgan Stanley MS +0.48% ▲ has taken a 7.1% stake in PHGE stock. It did so with its acquisition of 1,854,032 shares of PHGE.
https://www.tipranks.com/news/why-is-biomx-stock-phge-up-40-today
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.